Vistara | Natera

Most comprehensive
prenatal single-gene
screening test

Most comprehensive
prenatal single-gene
screening test

Most comprehensive
prenatal single-gene
screening test

Most comprehensive
prenatal single-gene
screening test

Conditions screened by Vistara have a combined incidence of 1 in 600 – higher than that of Down syndrome

Vistara screens cell-free DNA (cfDNA) for serious genetic conditions that affect quality of life and may benefit from medical and/or surgical intervention

Screened conditions include:

  • Noonan syndrome
  • Achondroplasia
  • Osteogenesis imperfecta
  • Rett syndrome
  • And 21 other single-gene disorders across 30 genes

SEE ALL CONDITIONS

Vistara screens cell-free DNA (cfDNA) for serious genetic conditions that affect quality of life and may benefit from medical and/or surgical intervention

Screened conditions include:

  • Noonan syndrome
  • Achondroplasia
  • Osteogenesis imperfecta
  • Rett syndrome
  • And 21 other single-gene disorders across 30 genes

SEE ALL CONDITIONS

Vistara screens cell-free DNA (cfDNA) for serious genetic conditions that affect quality of life and may benefit from medical and/or surgical intervention

Screened conditions include:

  • Noonan syndrome
  • Achondroplasia
  • Osteogenesis imperfecta
  • Rett syndrome
  • And 21 other single-gene disorders across 30 genes

SEE ALL CONDITIONS

Vistara screens cell-free DNA (cfDNA) for serious genetic conditions that affect quality of life and may benefit from medical and/or surgical intervention

Screened conditions include:

  • Noonan syndrome
  • Achondroplasia
  • Osteogenesis imperfecta
  • Rett syndrome
  • And 21 other single-gene disorders across 30 genes

SEE ALL CONDITIONS

Vistara has a combined analytical sensitivity and specificity of >99% in validation studies and no known false positives in commercial experience.

Vistara has a combined analytical sensitivity and specificity of >99% in validation studies and no known false positives in commercial experience.

Vistara has a combined analytical sensitivity and specificity of >99% in validation studies and no known false positives in commercial experience.

Vistara has a combined analytical sensitivity and specificity of >99% in validation studies and no known false positives in commercial experience.

Vistara identifies risk for single-gene disorders that may have otherwise gone undetected prenatally

  • Ultrasound findings are not a reliable indicator
  • Conditions are not detected with standard karyotype or microarray analysis
  • Family history is typically not a good indicator of risk (often de novo)
  • Early identification of these conditions is clinically actionable

Prenatal screening with Vistara can lead to improved delivery management and targeted neonatal care

Disorder Clinical actions
Noonan syndrome
  • Fetal echocardiogram
  • Labor and delivery management
  • Early assessment for learning differences
Achondroplasia
  • Labor and delivery management
  • Monitor for spinal stenosis
  • Early sleep studies to reduce risk of SIDS
Osteogenesis imperfecta
  • Labor and delivery management to avoid fractures
  • Neonatal care
  • Early recognition and treatment of fractures

Prenatal screening with Vistara can lead to improved delivery management and targeted neonatal care

Disorder Clinical actions
Noonan syndrome
  • Fetal echocardiogram
  • Labor and delivery management
  • Early assessment for learning differences
Achondroplasia
  • Labor and delivery management
  • Monitor for spinal stenosis
  • Early sleep studies to reduce risk of SIDS
Osteogenesis imperfecta
  • Labor and delivery management to avoid fractures
  • Neonatal care
  • Early recognition and treatment of fractures

Prenatal screening with Vistara can lead to improved delivery management and targeted neonatal care

Disorder Clinical actions
Noonan syndrome
  • Fetal echocardiogram
  • Labor and delivery management
  • Early assessment for learning differences
Achondroplasia
  • Labor and delivery management
  • Monitor for spinal stenosis
  • Early sleep studies to reduce risk of SIDS
Osteogenesis imperfecta
  • Labor and delivery management to avoid fractures
  • Neonatal care
  • Early recognition and treatment of fractures

Prenatal screening with Vistara can lead to improved delivery management and targeted neonatal care

Disorder Clinical actions
Noonan syndrome
  • Fetal echocardiogram
  • Labor and delivery management
  • Early assessment for learning differences
Achondroplasia
  • Labor and delivery management
  • Monitor for spinal stenosis
  • Early sleep studies to reduce risk of SIDS
Osteogenesis imperfecta
  • Labor and delivery management to avoid fractures
  • Neonatal care
  • Early recognition and treatment of fractures

Consider Vistara for the following indications

Back to Top